Effect of Secukinumab on Patient-Reported Outcomes in Patients With Active Ankylosing Spondylitis: A Phase III Randomized Trial (MEASURE 1).

Deodhar, Atul A   •   Dougados, Maxime   •   Baeten, Dominique L   •   Cheng-Chung Wei, James   •   Geusens, Piet   •   Readie, Aimee   •   Richards, Hanno B   •   Martin, Ruvie   •   Porter, Brian

published in: Arthritis & rheumatology (Hoboken, N.J.)